ID27153A - Senyawa inhibitor spla2 untuk mengobati penyakit - Google Patents

Senyawa inhibitor spla2 untuk mengobati penyakit

Info

Publication number
ID27153A
ID27153A IDW20002214A ID20002214A ID27153A ID 27153 A ID27153 A ID 27153A ID W20002214 A IDW20002214 A ID W20002214A ID 20002214 A ID20002214 A ID 20002214A ID 27153 A ID27153 A ID 27153A
Authority
ID
Indonesia
Prior art keywords
inhibitor compounds
treat disease
spla2 inhibitor
spla2
treat
Prior art date
Application number
IDW20002214A
Other languages
English (en)
Indonesian (id)
Inventor
William Louis Macias
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID27153A publication Critical patent/ID27153A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20002214A 1998-05-01 1999-04-20 Senyawa inhibitor spla2 untuk mengobati penyakit ID27153A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8387498P 1998-05-01 1998-05-01

Publications (1)

Publication Number Publication Date
ID27153A true ID27153A (id) 2001-03-08

Family

ID=22181224

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002214A ID27153A (id) 1998-05-01 1999-04-20 Senyawa inhibitor spla2 untuk mengobati penyakit

Country Status (20)

Country Link
US (1) US6340699B1 (cs)
EP (1) EP1084108A4 (cs)
JP (1) JP2002513783A (cs)
KR (1) KR20010043190A (cs)
CN (1) CN1299348A (cs)
AU (1) AU3656299A (cs)
BR (1) BR9910095A (cs)
CA (1) CA2330856A1 (cs)
CZ (1) CZ20004052A3 (cs)
EA (1) EA200001140A1 (cs)
HR (1) HRP20000739A2 (cs)
HU (1) HUP0102243A2 (cs)
ID (1) ID27153A (cs)
IL (1) IL139019A0 (cs)
NO (1) NO20005479L (cs)
PL (1) PL343708A1 (cs)
SK (1) SK16342000A3 (cs)
TR (1) TR200003194T2 (cs)
WO (1) WO1999057100A1 (cs)
ZA (1) ZA200005563B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
AU2001236440A1 (en) * 2000-01-25 2001-08-07 Eli Lilly And Company Method for the treatment of inflammation with spla2 inhibitors
AU2001267823A1 (en) 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
CZ2003176A3 (cs) * 2000-07-24 2003-06-18 Dov Global Technologies Inc. Prostředky z termoplastického superabsorpčního polymerního blendu a jejich příprava
EP1948604A1 (en) * 2005-11-03 2008-07-30 Ilypsa, Inc. Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors
KR20100135248A (ko) * 2008-04-01 2010-12-24 아스텔라스세이야쿠 가부시키가이샤 인돌리논 화합물
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
US9290752B2 (en) 2013-03-13 2016-03-22 Sunny Delight Beverages Co. Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356919A (en) 1991-05-30 1994-10-18 G. D. Searle & Co. Leukotriene B4 synthesis inhibitors
DE4218096A1 (de) 1992-06-02 1993-12-09 Boehringer Mannheim Gmbh Spiro-oxetane, Verfahren zu ihrer Herstellung und Arzneimittel
DE4323409A1 (de) 1993-07-13 1995-01-19 Boehringer Mannheim Gmbh Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel
EP1950200B1 (en) 1994-04-01 2012-01-11 Eli Lilly And Company [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor
WO1995033462A1 (en) * 1994-06-02 1995-12-14 Smithkline Beecham Corporation Anti-inflammatory compounds
NZ298145A (en) 1994-12-29 1998-08-26 Yamanouchi Pharma Co Ltd Monoclonal antibodies having inhibitory effect on type ii phospholipase a2, proteins forming part thereof, cells producing them, dna encoding them, recombinant vector comprising the dna and medicament
KR20000049210A (ko) 1996-10-30 2000-07-25 피터 지. 스트링거 치환된 트리시클릭류
GEP20032920B (en) * 1998-02-25 2003-03-25 Genetics Inst Inhibitors of Phospholipase Enzymes

Also Published As

Publication number Publication date
EP1084108A1 (en) 2001-03-21
NO20005479D0 (no) 2000-10-31
CN1299348A (zh) 2001-06-13
SK16342000A3 (sk) 2002-04-04
BR9910095A (pt) 2000-12-26
EP1084108A4 (en) 2005-01-12
HUP0102243A2 (hu) 2001-10-28
HRP20000739A2 (en) 2001-10-31
PL343708A1 (en) 2001-08-27
CZ20004052A3 (cs) 2002-05-15
EA200001140A1 (ru) 2001-04-23
US6340699B1 (en) 2002-01-22
NO20005479L (no) 2000-12-20
IL139019A0 (en) 2001-11-25
ZA200005563B (en) 2002-01-10
JP2002513783A (ja) 2002-05-14
TR200003194T2 (tr) 2001-03-21
WO1999057100A1 (en) 1999-11-11
KR20010043190A (ko) 2001-05-25
AU3656299A (en) 1999-11-23
CA2330856A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
DE69929020D1 (de) Rohrschuh
FI951553L (fi) 1H-indoli-glyoksyyliamidi-sPLA2-inhibiittoreita
CU23063A3 (es) Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas
NO20010760L (no) Griperenhet for brönntraktorer
NO20012995D0 (no) Forbindelse nyttige for behandling av inflammatoriske sykdommer
LTC1124961I2 (lt) Trombopoetino junginiai
NO20016319D0 (no) VLA-4 inhibitor-forbindelser
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
BR0010080B1 (pt) inibidores de renina
NO20011745L (no) Forbindelser
PT1194404E (pt) Inibidores de aspartil-protease
ID27346A (id) Peralatan pengenal suara
ID27004A (id) Senyawa-senyawa kalsilitik
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
NO20006662D0 (no) Fluorfenylresin-forbindelser
EP1093373A4 (en) OLIGONUCLEOTIDES INHIBITORS OF bcl-xL
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DE69908679D1 (de) Verfahren zum Weitern
NO20010060D0 (no) Vannrensing
IL139019A0 (en) Spla2 inhibitor compounds for treatment of disease
EP1025851A4 (en) alpha-GLUCOSIDASE HEMMER
PT1175417E (pt) Compostos substituidos de benzolactamas